As demands for aseptic manufacturing increase, partnerships among solutions providers will
become key to ensuring safe, versatile and optimized drug containment.
Topical, transdermal, and long-acting injectables are moving fast, and expectations for purity, performance, and regulatory readiness are higher than ever.
Quotient Sciences is a drug development and manufacturing accelerator providing integrated services across the entire development pathway, from candidate selection through commercial manufacturing. We offer global services for drug substance synthesis and manufacturing, formulation development, clinical trials and clinical & commercial manufacturing.
At Kindeva, we Manufacture More Tomorrows™ for patients worldwide. With best in-class facilities and comprehensive CDMO services, we provide more than manufacturing – we deliver strategic value. Our global network of 10 manufacturing and R&D sites offer exceptional integrated knowledge and capabilities, including Annex 1-compliant state-of-the-art aseptic fill finish capacity and next-generation sustainable inhalation propellant technology. By combining expertise in injectable, pulmonary, nasal, and dermal drug delivery, we help meet the demands of today and deliver the possibilities of tomorrow.
